Canada Pension Plan Investment Board Intercept Pharmaceuticals, Inc. Transaction History

Canada Pension Plan Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $743,038 - $1.18 Million	-48,062 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $386,445 - $754,698	19,992 Added 71.22%	48,062 $1.11 Million
Q4 2020 Feb 17, 2021	BUY	$24.48 - $42.47 $247,248 - $428,947	10,100 Added 56.2%	28,070 $693,000
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $73,997 - $101,161	-1,893 Reduced 9.53%	17,970 $745,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $467,980 - $922,332	10,021 Added 101.82%	19,863 $952,000

Q1 2020 May 13, 2020	BUY	$48.35 - $118.68 $276,271 - $678,137	5,714 Added 138.42%	9,842 $620,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $236,782 - $512,284	4,128 New	4,128 $512,000
Q3 2019 Nov 12, 2019	SELL	$58.69 - $80.46 $2.29 Million - $3.14 Million	-39,024 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$77.77 - $120.68 $684,376 - $1.06 Million	8,800 Added 29.12%	39,024 $3.11 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $716,274 - $941,304	7,800 Added 34.78%	30,224 $3.38 Million
Q4 2018 Feb 06, 2019	BUY	$85.79 - $126.46 $1.92 Million - $2.84 Million	22,424 New	22,424 $2.26 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.